End-of-day quote
NSE India S.E.
2025-03-13
5-day change
1st Jan Change
1,178.05 INR
+0.83%
-3.93%
+9.23%
Capitalization
316B
3.64B
3.35B
3.22B
2.82B
5.24B
5.76B
36.91B
13.99B
133B
13.64B
13.37B
540B
P/E ratio 2025 *
60.3x
P/E ratio 2026 *
50.1x Enterprise value
310B
3.56B
3.27B
3.15B
2.76B
5.13B
5.64B
36.13B
13.69B
131B
13.35B
13.08B
528B
EV / Sales 2025 *
8.33x
EV / Sales 2026 *
7.14x Free-Float
31.95%
Yield 2025 *
0.24%
Yield 2026 *
0.29%
Timeframe
1 day 1 week 1 month
Style
CandleStick End-of-day OHLC Mountain
Dynamic Chart
Global Health Limited Announces Company Secretary Changes
Mar. 02
CI
Global Health Limited Reports Earnings Results for the Half Year Ended December 31, 2024
Feb. 23
CI
Global Health Limited Announces Resignation of Karen Corry as Non-Executive Director
Feb. 09
CI
Jefferies Upgrades Global Health to Buy From Hold, Adjusts Price Target to INR1,360 From INR1,170
Feb. 06
MT
Crisil Affirms AA- Rating on Global Health's Bank Loans; Outlook Positive
Feb. 05
MT
Global Health Limited, Q3 2025 Earnings Call, Feb 05, 2025
Feb. 05
Global Health Posts Gains in Fiscal Q3 Consolidated Net Profit
Feb. 05
MT
Global Health Limited Proposes Capacity Addition
Feb. 04
CI
Global Health Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024
Feb. 04
CI
Global Health Dec-Quarter Consol PAT 1.43 Bln Rupees
Feb. 04
RE
Global Health Limited Appoints Brajesh Kumar Singh as Director - Projects
Jan. 14
CI
Global Health Limited Announces Resignation of Steven Strange as Non- Executive Director
Jan. 05
CI
Jefferies Adjusts Global Health's Price Target to INR1,170 From INR1,210, Keeps at Hold
Nov. 18
MT
More news
Jefferies Upgrades Global Health to Buy From Hold, Adjusts Price Target to INR1,360 From INR1,170
Feb. 06
MT
Jefferies Adjusts Global Health's Price Target to INR1,170 From INR1,210, Keeps at Hold
Nov. 18
MT
Jefferies Adjusts Global Health's Price Target to INR1,210 From INR1,400, Keeps at Hold
24-08-12
MT
Jefferies Downgrades Global Health to Hold From Buy, Adjusts Price Target to INR1,400 From INR1,470
24-05-21
MT
Jefferies Adjusts Global Health’s Price Target to INR 1,470 From INR1,120, Keeps at Buy
24-02-12
MT
More recommendations
1 day +0.83%
1 week -3.93%
Current month +2.47%
1 month +6.11%
3 months +6.54%
6 months +4.11%
Current year +9.23%
More quotes
Manager
Title Age Since
Chief Executive Officer
-
2017-09-14
Chief Tech/Sci/R&D Officer
-
2014-11-05
Compliance Officer
44
2021-07-07
Director
Title Age Since
Chairman
79
2014-02-06
Director/Board Member
59
2004-08-12
Director/Board Member
70
2015-10-05
More insiders
2025 * 2026 * Net sales
37.17B
428M
393M
378M
331M
615M
677M
4.34B
1.64B
15.68B
1.6B
1.57B
63.4B
43.51B
500M
460M
443M
387M
720M
792M
5.08B
1.92B
18.35B
1.88B
1.84B
74.21B
Net income
5.23B
60.17M
55.31M
53.23M
46.58M
86.61M
95.27M
610M
231M
2.21B
226M
221M
8.92B
6.4B
73.61M
67.66M
65.13M
56.99M
106M
117M
747M
283M
2.7B
276M
270M
10.92B
Net Debt
-6.7B
-77.07M
-70.85M
-68.19M
-59.67M
-111M
-122M
-782M
-296M
-2.83B
-289M
-283M
-11.43B
-5.64B
-64.9M
-59.66M
-57.42M
-50.24M
-93.42M
-103M
-658M
-249M
-2.38B
-243M
-238M
-9.62B
Global Health Limited (Medanta) is an India-based multi-specialty tertiary care provider in the North and East regions of India. Medanta delivers advanced, end-to-end healthcare in Delhi, Gurugram, Indore, Ranchi, Patna, and Lucknow through its network of approximately five hospitals. The Company provides healthcare services in over 30 medical specialties and engages over 1,700 doctors, which is led by experienced department heads. Its speciality treatments are in cardiac care, cancer care, neurosciences, gastrosciences, orthopedics, renal care, liver transplant, oncology, bone marrow transplant, obstetrics and gynecology, chest surgery, lung transplant, pediatric care, and others. Its facilities and services include medicine delivery, lab tests & diagnostics, book homecare services, elder care, air ambulance, and among others. The Companyâs subsidiaries are Global Health Patliputra Private Limited, Medanta Holdings Private Limited, and GHL Pharma & Diagnostic Private Limited.
More about the company
Date
Price
Change
Volume
25-03-13
1,178.05
₹
+0.83%
117,605
25-03-12
1,168.30
₹
-0.53%
91,125
25-03-11
1,174.50
₹
-2.85%
157,862
25-03-10
1,208.90
₹
-1.41%
183,945
End-of-day quote
NSE India S.E., March 12, 2025
More quotes
Last Close Price
1,178.05 INR
Average target price
1,271.80 INR
Spread / Average Target
+7.96%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1